GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Medicine Co Ltd (SHSE:600216) » Definitions » Cyclically Adjusted PB Ratio

Zhejiang Medicine Co (SHSE:600216) Cyclically Adjusted PB Ratio : 1.68 (As of Jun. 04, 2025)


View and export this data going back to 1999. Start your Free Trial

What is Zhejiang Medicine Co Cyclically Adjusted PB Ratio?

As of today (2025-06-04), Zhejiang Medicine Co's current share price is ¥15.04. Zhejiang Medicine Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ¥8.93. Zhejiang Medicine Co's Cyclically Adjusted PB Ratio for today is 1.68.

The historical rank and industry rank for Zhejiang Medicine Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

SHSE:600216' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.01   Med: 1.83   Max: 4.2
Current: 1.69

During the past years, Zhejiang Medicine Co's highest Cyclically Adjusted PB Ratio was 4.20. The lowest was 1.01. And the median was 1.83.

SHSE:600216's Cyclically Adjusted PB Ratio is ranked better than
55.46% of 696 companies
in the Drug Manufacturers industry
Industry Median: 1.975 vs SHSE:600216: 1.69

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Zhejiang Medicine Co's adjusted book value per share data for the three months ended in Mar. 2025 was ¥11.509. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥8.93 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Zhejiang Medicine Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Zhejiang Medicine Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Medicine Co Cyclically Adjusted PB Ratio Chart

Zhejiang Medicine Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.76 2.11 1.39 1.25 1.80

Zhejiang Medicine Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.03 1.26 1.96 1.80 1.50

Competitive Comparison of Zhejiang Medicine Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Medicine Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Medicine Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Medicine Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Zhejiang Medicine Co's Cyclically Adjusted PB Ratio falls into.


;
;

Zhejiang Medicine Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Zhejiang Medicine Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=15.04/8.93
=1.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Medicine Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Zhejiang Medicine Co's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=11.509/115.1156*115.1156
=11.509

Current CPI (Mar. 2025) = 115.1156.

Zhejiang Medicine Co Quarterly Data

Book Value per Share CPI Adj_Book
201506 7.058 99.500 8.166
201509 7.003 100.500 8.021
201512 7.045 100.600 8.062
201603 7.042 102.200 7.932
201606 7.125 101.400 8.089
201609 7.173 102.400 8.064
201612 7.247 102.600 8.131
201703 7.298 103.200 8.141
201706 7.235 103.100 8.078
201709 7.251 104.100 8.018
201712 7.549 104.500 8.316
201803 8.059 105.300 8.810
201806 7.987 104.900 8.765
201809 8.006 106.600 8.646
201812 7.922 106.500 8.563
201903 8.005 107.700 8.556
201906 8.015 107.700 8.567
201909 8.100 109.800 8.492
201912 8.145 111.200 8.432
202003 8.299 112.300 8.507
202006 7.595 110.400 7.919
202009 7.788 111.700 8.026
202012 7.952 111.500 8.210
202103 8.235 112.662 8.414
202106 8.513 111.769 8.768
202109 8.762 112.215 8.988
202112 9.096 113.108 9.257
202203 9.369 114.335 9.433
202206 9.190 114.558 9.235
202209 9.497 115.339 9.479
202212 9.594 115.116 9.594
202303 9.741 115.116 9.741
202306 10.000 114.558 10.049
202309 9.859 115.339 9.840
202312 9.980 114.781 10.009
202403 10.127 115.227 10.117
202406 10.344 114.781 10.374
202409 10.754 115.785 10.692
202412 11.073 114.893 11.095
202503 11.509 115.116 11.509

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Zhejiang Medicine Co  (SHSE:600216) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Zhejiang Medicine Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Zhejiang Medicine Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Medicine Co Business Description

Traded in Other Exchanges
N/A
Address
Comprehensive Building, No. 398 Mahuan Road, 3rd Floor, Building A, Binhai New City, Shaoxing, CHN, 312366
Zhejiang Medicine Co Ltd is a china-based pharmaceutical company. The company manufactures fat-soluble vitamins, vitamins, quinolones, and antibiotic-resistant antibiotics, vitamin E, natural vitamin E, beta-carotene, cantharidin, vancomycin hydrochloride, and teicoplanin.
Executives
Zhu Jin Lin senior management
Chu Zhen Hua Director
Liang Bi Rong Director
Yu Yu Qing Director
Ping Jian Hong senior management
An Yong Bin senior management
Wang Xiao Ping senior management
Liang Li Ping senior management
Li Qi Rong senior management
Zhu Shao Ming Supervisors
Wang Hong Wei senior management
Zhang Ding Feng senior management
Ma Wen Xin Director
Zhao Jun Xing senior management
Lv Yong Hui Director

Zhejiang Medicine Co Headlines

No Headlines